SS Innovations International (SSII) Income from Continuing Operations (2016 - 2026)
SS Innovations International (SSII) reported Income from Continuing Operations of 3582571.0 for Q1 2026, up 20.18% on a YoY basis from 2981023.5 in Q1 2025, and down 165.34% sequentially from 5482964.0 in Q4 2025.
SS Innovations International (SSII) Income from Continuing Operations (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Income from Continuing Operations data on file, last reported at 3582571.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 20.18% year-over-year to 3582571.0; the trailing twelve-month figure through Mar 2026 stood at 2074262.0 (down 180.5% YoY), and the FY2025 full-year result was 8180947.0, down 1052.11% from the prior year.
- Income from Continuing Operations retreated to 3582571.0 in Q1 2026, from 5482964.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 12899882.0 in Q4 2024 to a low of 9592378.0 in Q4 2023.
- A 5-year average of 1534698.88 and a median of 1499845.0 in 2023 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations tumbled 1189.82% in 2023 and jumped 234.48% in 2024, its largest moves.
- Tracing SSII's Income from Continuing Operations over 5 years: stood at 998076.0 in 2022, then plunged by 861.09% to 9592378.0 in 2023, then jumped by 234.48% to 12899882.0 in 2024, then tumbled by 57.5% to 5482964.0 in 2025, then slumped by 165.34% to 3582571.0 in 2026.
- Business Quant data shows SSII's Income from Continuing Operations at 3582571.0 in Q1 2026, 5482964.0 in Q4 2025, and 3717964.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | -3.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.58 Mn |
| Dec 31, 2025 | 5.48 Mn |
| Sep 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -256,691.00 |
| Mar 31, 2025 | -4.49 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Sep 30, 2024 | -2.56 Mn |
| Jun 30, 2024 | -3.27 Mn |
| Mar 31, 2024 | -7.77 Mn |
| Dec 31, 2023 | -9.59 Mn |
| Sep 30, 2023 | -1.50 Mn |
| Jun 30, 2023 | -4.36 Mn |
| Mar 31, 2023 | -1.04 Mn |
| Dec 31, 2022 | -998,076.00 |
| Sep 30, 2022 | -456,494.00 |
| Jun 30, 2022 | -788,423.00 |
| Mar 31, 2022 | -80,421.00 |
| Dec 31, 2021 | -352,956.00 |
| Sep 30, 2021 | -418,209.00 |
| Jun 30, 2021 | -412,314.00 |